IceCure Medical (ICCM) Equity Ratio (2020 - 2025)

IceCure Medical (ICCM) has disclosed Equity Ratio for 6 consecutive years, with 0.65 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 18.76% to 0.65 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.65 through Dec 2025, up 18.76% year-over-year, with the annual reading at 0.65 for FY2025, 18.76% up from the prior year.
  • Equity Ratio for Q4 2025 was 0.65 at IceCure Medical, up from 0.55 in the prior quarter.
  • The five-year high for Equity Ratio was 0.84 in Q4 2022, with the low at 0.55 in Q4 2024.
  • Average Equity Ratio over 5 years is 0.72, with a median of 0.74 recorded in 2023.
  • The sharpest move saw Equity Ratio soared 51.39% in 2021, then decreased 25.96% in 2024.
  • Over 5 years, Equity Ratio stood at 0.84 in 2021, then rose by 0.84% to 0.84 in 2022, then fell by 11.98% to 0.74 in 2023, then dropped by 25.96% to 0.55 in 2024, then increased by 18.76% to 0.65 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.65, 0.55, and 0.74 for Q4 2025, Q4 2024, and Q4 2023 respectively.